TDENV-PIV

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

DengueDengue Virus

Phase 1

TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant

WithdrawnNCT03110952

U.S. Army Medical Research and Development CommandDengue

Start: 2016-01-31End: 2018-04-30Updated: 2017-04-12

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

U.S. Army Medical Research and Development CommandDengue Virus

Start: 2017-11-08End: 2021-12-31Updated: 2021-03-26